Related Experiment Videos
Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease
1Department of Cardiac Surgery, Karl-Franzens University School of Medicine, Graz, Austria. olaf.stanger@kfunigraz.ac.at
Insights
Elevated homocysteine levels are a significant risk factor for vascular disease. Lowering homocysteine through vitamin supplementation may protect blood vessels and improve endothelial function.
Area of Science:
- Vascular Biology
- Cardiovascular Disease
- Endothelial Function
Background:
- Elevated plasma homocysteine is a major risk factor for atherosclerosis and thrombosis.
- Moderate hyperhomocysteinemia increases mortality risk in cardiovascular disease patients.
- Mechanisms of homocysteine-induced vascular damage are not fully understood.
Purpose of the Study:
- To investigate the role of homocysteine in endothelium-dependent function.
- To understand the clinical implications for cardiovascular disease treatment.
- To explore the reversibility of homocysteine's damaging effects on endothelium.
Main Methods:
- Examining endothelium-dependent function in healthy and cardiovascular patients.
- Assessing the impact of acute and chronic homocysteine exposure on endothelial cells.
- Investigating the effects of homocysteine on vascular homeostasis and morphology.
Main Results:
- Homocysteine exposure impairs endothelial function, altering homeostasis and vessel wall morphology.
- Endothelial dysfunction is an early event in vascular pathology.
- Damaging effects of hyperhomocysteinemia on endothelium are partially reversible.
Conclusions:
- Homocysteine significantly impacts endothelial function, contributing to vascular damage.
- Vitamin supplementation may offer vasoprotective effects by lowering homocysteine.
- Further research into homocysteine-lowering therapies is warranted for cardiovascular disease prevention and treatment.
Abstract:
Elevated plasma homocyst(e)ine is currently accepted as a major, independent risk factor for atherosclerosis and venous thrombosis. Even moderate hyperhomocyst(e)inemia is prospectively associated with increased risk of mortality in patients with cardiovascular disease. However, the underlying mechanisms resulting in vascular damage are not clearly defined. The endothelium exerts fundamental control on the vascular tone, coagulation and fibrinolysis. Injury to the endothelium followed by dysfunction is an early key event preceding manifestation of vessel pathology. Acute and chronic exposure of endothelium to homocyst(e)ine induces impairment of endothelial function associated with altered homeostasis and morphologic changes of the vessel wall. Investigations of the role of homocyst(e)ine in the endothelium-dependent function in healthy subjects and cardiovascular patients have recently added important clinical insight with implications for the treatment of cardiovascular disease. Importantly, the damaging effects of hyperhomocyst(e)inemia on endothelial function are, at least in part, reversible in patients with established vascular disease, supporting further the hypothesis that homocyst(e)ine-lowering through vitamin supplementation may have vasoprotective effects.